(2-methylpropyl)({[4-(trifluoromethyl)phenyl]methyl})amine, 95.0%, 2g

5-(4-tert-butylphenyl)-4,5-dihydroisoxazole-3-carboxylic acid, 10g

(S)-tert-Butyl (5,6-diamino-6-oxohexyl)carbamate, 98%, 250mg

1-(CARBOXYMETHYL)-2-OXO-1,2-DIHYDROPYRIDINE-3-CARBOXYLIC ACID, 95.0%, 250mg

5-Amino-1-(3-chloro-4-methylphenyl)-1H-1,2,3-triazole-4-carboxamide, 95.0%, 500mg

Cerium(III) chloride hydrate 99.99% 100 g

3-Chlorophthalic acid anhydride, 95.0%, 100g

2-Bromobenzylamine, 97.0%, 1g

E-Plan phase EPLPHi S100x/1.25 oil immersion infinity corrected IOS objective. Working distance 0.36 mm

z-d-glu-ome, 95.0%, 25g

2-Fluoro-5-(methoxymethoxy)phenylboronic acid, 97%, 5g

5-Bromo-1-(triisopropylsilyl)-1H-pyrrolo[2,3-b]pyridine, 95.0%, 25g

2-Bromo-5-chloro-3-methylpyridine, 98.0%, 100g